0

Journal Articles

in Movement Disorders
 41-60 of 768 Articles
JAMA Neurology | 
Original Contribution |  June 01, 2012
Mutational Origin of Machado-Joseph Disease in the Australian Aboriginal Communities of Groote Eylandt and Yirrkala
Sandra Martins, PhD; Bing-Wen Soong, MD, PhD; Virginia C. N. Wong, MD, PhD; et al.
Arch Neurol. 2012;69(6):746-751. doi:10.1001/archneurol.2011.2504.
JAMA | 
JAMA Clinical Challenge |  May 23, 2012 FREE
Progressive Confusion, Memory Loss, and Gait Ataxia in an Adult
Brian J. Dlouhy, MD; Jeremy D. W. Greenlee, MD
JAMA. 2012;307(20):2195-2196. doi:10.1001/jama.2012.3447.
JAMA Neurology | 
Research Letters |  May 01, 2012 FREE
Two Faces of the Same Coin: Benign Familial Infantile Seizures and Paroxysmal Kinesigenic Dyskinesia Caused by PRRT2 Mutations
Alexander Schmidt, MD; Kishore R. Kumar, MBBS, FRACP; Katharina Redyk, MD; et al.
Arch Neurol. 2012;69(5):668-670. doi:10.1001/archneurol.2012.187.
JAMA Neurology | 
Original Contributions |  May 01, 2012
Predictors of Survival in Patients With Parkinson Disease
Allison W. Willis, MD; Mario Schootman, PhD; Nathan Kung, MD; et al.
Arch Neurol. 2012;69(5):601-607. doi:10.1001/archneurol.2011.2370.
INCLUDES: CME
JAMA Neurology | 
Observation |  April 01, 2012 FREE
Use of Acetazolamide in Sulfonamide-Allergic Patients With Neurologic Channelopathies
Daniel Platt, MD; Robert C. Griggs, MD
Arch Neurol. 2012;69(4):527-529. doi:10.1001/archneurol.2011.2723.
INCLUDES: CME
JAMA Neurology | 
Original Contributions |  April 01, 2012
Familial Adult Myoclonic Epilepsy:  Recognition of Mild Phenotypes and Refinement of the 2q Locus
Douglas E. Crompton, MA, MBBS, PhD, MRCP(UK); Lynette G. Sadleir, MBChB, MD; Catherine J. Bromhead, BSc(Hons); et al.
Arch Neurol. 2012;69(4):474-481. doi:10.1001/archneurol.2011.584.
INCLUDES: , Supplemental Content
JAMA Neurology | 
Original Contributions |  April 01, 2012
Factors Influencing Disease Progression in Autosomal Dominant Cerebellar Ataxia and Spastic Paraplegia
Sophie Tezenas du Montcel, MD, PhD; Perrine Charles, MD, PhD; Cyril Goizet, MD, PhD; et al.
Arch Neurol. 2012;69(4):500-508. doi:10.1001/archneurol.2011.2713.
INCLUDES: , Supplemental Content
JAMA Otolaryngology–Head & Neck Surgery | 
Clinical Note |  April 01, 2012
Objective Tinnitus From Middle Ear Myoclonus
Pedro Costa de Araujo, MD; Julian Savage, MBBS, FRCS(ORL-HNS), Cert Med Ed
Arch Otolaryngol Head Neck Surg. 2012;138(4):421. doi:10.1001/archoto.2012.72.
JAMA | 
Lab Reports |  March 07, 2012
Parkinson Disease Protein
Tracy Hampton, PhD
JAMA. 2012;307(9):904. doi:10.1001/jama.2012.224.
JAMA Neurology | 
Observation |  March 01, 2012 FREE
Partial Trisomy 4q Associated With Young-Onset Dopa-Responsive Parkinsonism
Gaëtan Garraux, MD, PhD; Jean-Hubert Caberg, PhD; Jean-François Vanbellinghen, MSc; et al.
Arch Neurol. 2012;69(3):398-400. doi:10.1001/archneurol.2011.802.
JAMA Neurology | 
Images in Neurology |  January 01, 2012
Topiramate Effect in Opsoclonus-Myoclonus-Ataxia Syndrome
Thiago Dias Fernandes, MD; Rodrigo Bazan, MD; Luiz Eduardo Betting, MD, PhD; et al.
Arch Neurol. 2012;69(1):133. doi:10.1001/archneurol.2011.717.
JAMA Neurology | 
Original Contributions |  January 01, 2012
Association of Sequence Alterations in the Putative Promoter of RAB7L1 With a Reduced Parkinson Disease Risk
Ziv Gan-Or, BMedSci; Anat Bar-Shira, PhD; Dvir Dahary, MSc; et al.
Arch Neurol. 2012;69(1):105-110. doi:10.1001/archneurol.2011.924.
INCLUDES: , Supplemental Content
JAMA Neurology | 
Correspondence |  December 01, 2011
Parkinson Disease and Vitamin D: An Interplay Between Genes and the Environment?
Gabriele C. DeLuca, MD, DPhil; Grace Li, BA; Sreeram Ramagopalan, DPhil
Arch Neurol. 2011;68(12):1615-1616. doi:10.1001/archneurol.2011.1078.
JAMA Neurology | 
Original Contributions |  December 01, 2011
The APOE ε2 Allele Increases the Risk of Earlier Age at Onset in Machado-Joseph Disease
Conceição Bettencourt, PhD; Mafalda Raposo, BSc; Nadiya Kazachkova, PhD; et al.
Arch Neurol. 2011;68(12):1580-1583. doi:10.1001/archneurol.2011.636.
JAMA Neurology | 
Original Contributions |  December 01, 2011
Neurodegeneration Across Stages of Cognitive Decline in Parkinson Disease
Daniel Weintraub, MD; Jimit Doshi, MS; Deepthi Koka, MS; et al.
Arch Neurol. 2011;68(12):1562-1568. doi:10.1001/archneurol.2011.725.
INCLUDES: , Supplemental Content
JAMA Neurology | 
Original Contributions |  December 01, 2011
Ten-Year Outcome of Subthalamic Stimulation in Parkinson Disease:  A Blinded Evaluation
Anna Castrioto, MD; Andres M. Lozano, MD, PhD; Yu-Yan Poon, RN; et al.
Arch Neurol. 2011;68(12):1550-1556. doi:10.1001/archneurol.2011.182.
INCLUDES: , Supplemental Content
JAMA Psychiatry | 
Original Article |  December 01, 2011 FREE
Reinforcement Learning and Gilles de la Tourette Syndrome:  Dissociation of Clinical Phenotypes and Pharmacological Treatments
Yulia Worbe, MD, PhD; Stefano Palminteri, MSc; Andreas Hartmann, MD; et al.
Arch Gen Psychiatry. 2011;68(12):1257-1266. doi:10.1001/archgenpsychiatry.2011.137.
INCLUDES: , Supplemental Content
JAMA Psychiatry | 
Original Article |  December 01, 2011 FREE
Early Risk Factors for Hyperactivity-Impulsivity and Inattention Trajectories From Age 17 Months to 8 Years
Cédric Galéra, MD, PhD; Sylvana M. Côté, PhD; Manuel P. Bouvard, MD; et al.
Arch Gen Psychiatry. 2011;68(12):1267-1275. doi:10.1001/archgenpsychiatry.2011.138.
JAMA Neurology | 
Observation |  October 01, 2011 FREE
Chorea-Acanthocytosis Genotype in the Original Critchley Kentucky Neuroacanthocytosis Kindred
Antonio Velayos-Baeza, PhD; Elke Holinski-Feder, MD, PhD; Birgit Neitzel; et al.
Arch Neurol. 2011;68(10):1330-1333. doi:10.1001/archneurol.2011.239.
INCLUDES: , Supplemental Content
JAMA Neurology | 
Original Contributions |  October 01, 2011
Purkinje Cell Cytoplasmic Autoantibody Type 1 Accompaniments:  The Cerebellum and Beyond
Andrew McKeon, MD; Jennifer A. Tracy, MD; Sean J. Pittock, MD; et al.
Arch Neurol. 2011;68(10):1282-1289. doi:10.1001/archneurol.2011.128.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Editorial  |  March 4, 2013
Lessons for Parkinson Disease From the Parkin Genotype
J. Eric Ahlskog, PhD, MD
JAMA Neurology
Correspondence  |  May 01, 2013
A Mild Form of Adult-Onset Opsoclonus-Myoclonus Syndrome Associated With Antiglutamate Receptor Antibodies
Taiki Kambe, MD; Yukitoshi Takahashi, MD; Yoshiaki Furukawa, MD
JAMA Neurology
Correspondence  |  May 01, 2013
A Mild Form of Adult-Onset Opsoclonus-Myoclonus Syndrome Associated With Antiglutamate Receptor Antibodies—Reply
Andrew McKeon, MD; Sean Pittock, MD
JAMA Neurology
Original Contribution  |  March 25, 2013
Prognosis of Mild Cognitive Impairment in Early Parkinson Disease:  The Norwegian ParkWest Study
Kenn Freddy Pedersen, MD, PhD; Jan Petter Larsen, MD, PhD; Ole-Bjorn Tysnes, MD, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems